JP2014533518A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533518A5
JP2014533518A5 JP2014542951A JP2014542951A JP2014533518A5 JP 2014533518 A5 JP2014533518 A5 JP 2014533518A5 JP 2014542951 A JP2014542951 A JP 2014542951A JP 2014542951 A JP2014542951 A JP 2014542951A JP 2014533518 A5 JP2014533518 A5 JP 2014533518A5
Authority
JP
Japan
Prior art keywords
polypeptide
ugt
seq
amino acid
set forth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014542951A
Other languages
English (en)
Japanese (ja)
Other versions
JP6084983B2 (ja
JP2014533518A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/002857 external-priority patent/WO2013076577A1/en
Publication of JP2014533518A publication Critical patent/JP2014533518A/ja
Publication of JP2014533518A5 publication Critical patent/JP2014533518A5/ja
Application granted granted Critical
Publication of JP6084983B2 publication Critical patent/JP6084983B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014542951A 2011-11-23 2012-11-19 モグロシド化合物の酵素的合成のための方法および材料 Active JP6084983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161563303P 2011-11-23 2011-11-23
US61/563,303 2011-11-23
PCT/IB2012/002857 WO2013076577A1 (en) 2011-11-23 2012-11-19 Methods and materials for enzymatic synthesis of mogroside compounds

Publications (3)

Publication Number Publication Date
JP2014533518A JP2014533518A (ja) 2014-12-15
JP2014533518A5 true JP2014533518A5 (enExample) 2016-09-29
JP6084983B2 JP6084983B2 (ja) 2017-02-22

Family

ID=47624376

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014542951A Active JP6084983B2 (ja) 2011-11-23 2012-11-19 モグロシド化合物の酵素的合成のための方法および材料

Country Status (14)

Country Link
US (2) US9920349B2 (enExample)
EP (1) EP2783009B1 (enExample)
JP (1) JP6084983B2 (enExample)
KR (1) KR101791597B1 (enExample)
CN (1) CN103958693B (enExample)
AU (2) AU2012342114B2 (enExample)
BR (1) BR112014012543A2 (enExample)
CA (1) CA2853677C (enExample)
IN (1) IN2014CN03557A (enExample)
MX (1) MX342851B (enExample)
MY (1) MY170686A (enExample)
RU (1) RU2633644C2 (enExample)
SG (1) SG11201401927PA (enExample)
WO (1) WO2013076577A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ708078A (en) 2010-06-02 2017-01-27 Evolva Nutrition Inc Recombinant production of steviol glycosides
SG10201606569VA (en) 2011-08-08 2016-09-29 Evolva Sa Recombinant production of steviol glycosides
KR101791597B1 (ko) 2011-11-23 2017-10-30 에볼바 에스아 모그로사이드 화합물을 효소에 의해 합성하기 위한 방법 및 재료
TW201402599A (zh) * 2012-05-30 2014-01-16 Suntory Holdings Ltd 甜菊糖苷糖苷轉化酵素及編碼該酵素之基因
BR112015013129A2 (pt) 2012-12-04 2017-07-11 Evolva Sa métodos e materiais para a biossíntese de compostos mogrosida
CA2900882A1 (en) 2013-02-11 2014-08-14 Evolva Sa Efficient production of steviol glycosides in recombinants hosts
CN114410493A (zh) 2014-08-11 2022-04-29 埃沃尔瓦公司 在重组宿主中生产甜菊醇糖苷
SG11201701677UA (en) 2014-09-09 2017-04-27 Evolva Sa Production of steviol glycosides in recombinant hosts
IL287789B2 (en) 2014-09-11 2024-05-01 The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo Mogroside compounds, methods for their preparation, preparations including them and their uses
CA2963300C (en) 2014-10-01 2024-04-30 Evolva Sa Methods and materials for biosynthesis of mogroside compounds
EP3208342A4 (en) 2014-10-17 2018-07-04 Suntory Holdings Limited Mogrol glycosyltransferase and gene encoding same
WO2016117549A1 (ja) 2015-01-20 2016-07-28 サントリーホールディングス株式会社 モグロシドの調製方法
JP2018503388A (ja) 2015-01-30 2018-02-08 エヴォルヴァ エスアー.Evolva Sa. 組み換え宿主におけるステビオールグリコシドの生産
CA2979931A1 (en) 2015-03-16 2016-09-22 Dsm Ip Assets B.V. Udp-glycosyltransferases
CA2995067A1 (en) 2015-08-07 2017-02-16 Evolva Sa Production of steviol glycosides in recombinant hosts
SG11201803603WA (en) 2015-10-29 2018-05-30 Senomyx Inc High intensity sweeteners
CN106924274B (zh) * 2015-12-29 2019-01-04 成都普睿法药物研发有限公司 葫芦烷型四环三萜类化合物抗肺纤维化应用
MY198001A (en) 2016-04-13 2023-07-25 Evolva SA Production of steviol glycoside in recombinant hosts
CN109312378A (zh) 2016-05-16 2019-02-05 埃沃尔瓦公司 在重组宿主中产生甜菊醇糖苷
US20190144907A1 (en) * 2016-05-16 2019-05-16 Evolva Sa Production of steviol glycosides in recombinant hosts
WO2018016483A1 (ja) * 2016-07-19 2018-01-25 サントリーホールディングス株式会社 モグロールまたはモグロール配糖体の生産方法
EP3535406A1 (en) 2016-11-07 2019-09-11 Evolva SA Production of steviol glycosides in recombinant hosts
CN111108213B (zh) * 2017-05-03 2024-12-13 弗门尼舍公司 制备高强度甜味剂的方法
WO2018213683A1 (en) 2017-05-19 2018-11-22 The Coca-Cola Company Siamenoside i sweetened compositions and uses of the same
RU2762719C2 (ru) 2017-06-02 2021-12-22 Живодан Са Композиция, модифицирующая сладость
US11248248B2 (en) 2017-06-15 2022-02-15 Evolva Sa Production of mogroside compounds in recombinant hosts
CN107189976B (zh) * 2017-07-28 2022-03-11 李华政 促进罗汉果ugt72b21基因表达的方法
BR112021008929A2 (pt) 2018-11-07 2021-08-17 Firmenich Incorporated métodos para fazer edulcorantes de alta intensidade
MX2021005219A (es) 2018-11-07 2021-06-18 Firmenich Incorporated Metodos para hacer edulcorantes de alta intensidad.
CA3118924A1 (en) 2018-11-09 2020-05-14 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
CN110669094B (zh) * 2019-10-14 2021-12-21 上海交通大学 罗汉果新苷及其制备方法
KR102362135B1 (ko) * 2019-10-25 2022-02-14 고려대학교 산학협력단 테르펜 당쇄 부가 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 조성물
US20240060078A1 (en) * 2020-03-17 2024-02-22 The Coca-Cola Company Novel mogroside production system and methods
CA3179775A1 (en) 2020-04-20 2021-10-28 Givaudan Sa Compositions
GB202007984D0 (en) 2020-05-28 2020-07-15 Givaudan Sa Compositions
CN112063647B (zh) * 2020-09-17 2023-05-02 云南农业大学 酿酒酵母重组菌Cuol01的构建方法、酿酒酵母重组菌Cuol02及应用
CN116064712B (zh) * 2022-10-08 2025-05-06 中国药科大学 一种罗汉果醇的生物合成方法
CN121127603A (zh) 2023-04-20 2025-12-12 帝斯曼知识产权资产管理有限公司 用于产生罗汉果苷的菌株和方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399321B1 (en) * 1999-08-18 2002-06-04 National Research Council Of Canada Methods for screening UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity and nucleic acid encoding for UGGT
EP1510573A1 (en) * 2003-09-01 2005-03-02 Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung Method for detoxification of mycotoxins
US20080148432A1 (en) * 2005-12-21 2008-06-19 Mark Scott Abad Transgenic plants with enhanced agronomic traits
WO2006092449A2 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
US8257948B1 (en) * 2011-02-17 2012-09-04 Purecircle Usa Method of preparing alpha-glucosyl Stevia composition
US8956677B2 (en) 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
RU2424734C2 (ru) * 2005-11-23 2011-07-27 Дзе Кока-Кола Компани Композиция интенсивного подсластителя с антиоксидантом и подслащенные ею композиции
US7927851B2 (en) 2006-03-21 2011-04-19 Vineland Research And Innovation Centre Compositions having ent-kaurenoic acid 13-hydroxylase activity and methods for producing same
US20100143975A1 (en) * 2006-11-22 2010-06-10 The University Of York Monoterpenoid modifying enzymes
WO2008065370A2 (en) * 2006-12-01 2008-06-05 The University Of York Sesquiterpenoid modifying enzymes
GB0904639D0 (en) * 2009-03-18 2009-04-29 Univ York Assay
NZ708078A (en) 2010-06-02 2017-01-27 Evolva Nutrition Inc Recombinant production of steviol glycosides
KR101791597B1 (ko) 2011-11-23 2017-10-30 에볼바 에스아 모그로사이드 화합물을 효소에 의해 합성하기 위한 방법 및 재료
BR112015013129A2 (pt) 2012-12-04 2017-07-11 Evolva Sa métodos e materiais para a biossíntese de compostos mogrosida

Similar Documents

Publication Publication Date Title
JP2014533518A5 (enExample)
Schoeman et al. Coronavirus envelope protein: current knowledge
Baker et al. Designer oncolytic adenovirus: coming of age
Duan et al. The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens
Ren et al. A novel mechanism for the inhibition of interferon regulatory factor-3-dependent gene expression by human respiratory syncytial virus NS1 protein
Dawe et al. The S4 genome segment of baboon reovirus is bicistronic and encodes a novel fusion-associated small transmembrane protein
JP2018520997A5 (enExample)
JP2012095652A5 (enExample)
Kaukinen et al. Interaction between molecules of hantavirus nucleocapsid protein
Reuter et al. The nucleocapsid protein of hantaviruses: much more than a genome-wrapping protein
Maeda et al. The intracellular association of the nucleocapsid protein (NP) of hantaan virus (HTNV) with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9)
JP2012531208A5 (enExample)
EP2385107A8 (en) Lentiviral vector based immunological compounds against malaria
Lu et al. Penton-dodecahedral particles trigger opening of intercellular junctions and facilitate viral spread during adenovirus serotype 3 infection of epithelial cells
Florian et al. Characterization of the anti‐HBV activity of HLP1–23, a human lactoferrin‐derived peptide
Molouki et al. The matrix (M) protein of Newcastle disease virus binds to human bax through its BH3 domain
Wilcock et al. The vaccinia virus A40R gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface
RU2015148190A (ru) Слитые полипептиды и вакцины
CN102311500B (zh) 一种抗病毒融合蛋白及其应用
AU2016313660B2 (en) Polypeptide carrier for presenting target polypeptide and uses thereof
CN104404005A (zh) 禽流感病毒ha基因重组腺病毒的制备方法
Liang et al. The role of F1 ATP synthase beta subunit in WSSV infection in the shrimp, Litopenaeus vannamei
JP2010279373A5 (enExample)
Zhu et al. Transcription and identification of a novel envelope protein (VP124) gene of shrimp white spot syndrome virus
Jie et al. The C-terminal region of envelope protein VP38 from white spot syndrome virus is indispensable for interaction with VP24